ClinicalTrials.Veeva

Menu

A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand

CooperVision logo

CooperVision

Status

Completed

Conditions

Corneal Staining

Treatments

Other: Multipurpose Solution #1
Other: Multipurpose Solution #4
Other: Multipurpose Solution #2
Other: Mutlipurpose Solution #3

Study type

Interventional

Funder types

Industry

Identifiers

NCT01335750
CV-09-64, Sterling IRB 3576

Details and patient eligibility

About

This study is a clinical comparison of the biocompatibility of several multipurpose solutions, Renu Fresh, Optifree Replenish, and ClearCare, and saline as a control solution among adapted hydrogel contact lens wearers wearing Avaira (enfilcon A) contact lenses at one research site.

Enrollment

32 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Informed Consent and HIPAA document read, signed, and dated.
  • Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with hydrogel or silicone hydrogel contact lenses.
  • Successfully wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis for at least two weeks prior to the study.

Exclusion criteria

  • History of hypersensitivity
  • Evidence or history of epithelial herpes simplex keratitis (dendritic keratitis; vaccinia, active or recent varicella, viral disease of the cornea and/or conjunctiva and/or eyelids; bacterial infection of the eye; and/or fungal disease of the eye
  • One functional eye or a monofit eye
  • Ocular conditions such as active acute blepharitis, conjunctival infections, and iritis
  • Type 2 (macropunctate) or greater corneal staining in any region in either eye as observed by slit-lamp at Visit 1 of each study period
  • Sum of the type of corneal staining greater than or equal to 4 across entire cornea in either eye as observed by slit-lamp at Visit 1 of each study period
  • Conjunctival staining covering greater than or equal to 20% in 2 or more corneal regions in either eye as observed by slit-lamp at Visit 1 of each study period
  • Conjunctival injection greater than Grade 2 (moderate-diffuse redness) in either eye as observed by slit-lamp at Visit 1 of each study period
  • Abnormal lenticular opacity in the visual axis of the lens in either eye
  • Use of concomitant topical Rx or over-the-counter (OTC) ocular medications
  • History of seasonal allergies with significant ocular side effects which may have an adverse impact on contact lens wear
  • Pregnant or lactating females

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

32 participants in 4 patient groups

Multipurpose Solution #1
Experimental group
Description:
B\&L Renu Fresh Multipurpose Solution
Treatment:
Other: Mutlipurpose Solution #3
Other: Multipurpose Solution #2
Other: Multipurpose Solution #4
Other: Multipurpose Solution #1
Multipurpose Solution #2
Experimental group
Description:
OptiFree Replenish Multipurpose Solution
Treatment:
Other: Mutlipurpose Solution #3
Other: Multipurpose Solution #2
Other: Multipurpose Solution #4
Other: Multipurpose Solution #1
Multipurpose Solution #3
Experimental group
Description:
Ciba ClearCare Multipurpose Solution
Treatment:
Other: Mutlipurpose Solution #3
Other: Multipurpose Solution #2
Other: Multipurpose Solution #4
Other: Multipurpose Solution #1
Multipurpose Solution #4
Active Comparator group
Description:
Saline Solution
Treatment:
Other: Mutlipurpose Solution #3
Other: Multipurpose Solution #2
Other: Multipurpose Solution #4
Other: Multipurpose Solution #1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems